By integrating next‐generation sequencing and comprehensive genetic analyses, which revealed no germline RB1 or other hereditary cancer syndrome mutations, we confirmed the nonhereditary nature of the patient's retinoblastoma. This evidence concerns the gene RB1 and Inherited cancer-predisposing syndrome.